Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06421675
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-20
First Post:
2024-03-11
Brief Title:
Outpatient and Intermittent Dosing of Elranatamab in RelapsedRefractory Multiple Myeloma
Sponsor:
Ontario Clinical Oncology Group OCOG
Organization:
Ontario Clinical Oncology Group OCOG